Close

Alison Galvani

Professor

Education

Affiliations

Projects

Papers

Pandey A, Galvani AP. (2019). The global burden of HIV and prospects for control. The lancet. HIV

Thomson N, Littlejohn M, Strathdee SA, Southby RF, Coghlan B, Rosenfeld JV, Galvani AP. (2019). Harnessing synergies at the interface of public health and the security sector. Lancet (London, England), 393(10168)

Wells CR, Pandey A, Parpia AS, Fitzpatrick MC, Meyers LA, Singer BH, Galvani AP. (2019). Ebola vaccination in the Democratic Republic of the Congo. Proceedings of the National Academy of Sciences of the United States of America, 116(20)

Pandey A, Galvani AP. (2019). Quantifying risk factors to guide progress towards leprosy elimination. The Lancet. Global health, 7(9)

Pandey A, Fitzpatrick MC, Galvani AP. (2019). Metrics and benchmarks for HIV transition - Authors' reply. The lancet. HIV, 6(3)

King CH, Galvani AP. (2018). Underestimation of the global burden of schistosomiasis. Lancet (London, England), 391(10118)

Sah P, Medlock J, Fitzpatrick MC, Singer BH, Galvani AP. (2018). Optimizing the impact of low-efficacy influenza vaccines. Proceedings of the National Academy of Sciences of the United States of America, 115(20)

Fitzpatrick MC, Gray GE, Galvani AP. (2018). The Challenge of Vanquishing HIV for the Next Generation-Facing the Future. JAMA pediatrics, 172(7)

Marshall BDL, Goedel WC, King MRF, Singleton A, Durham DP, Chan PA, Townsend JP, Galvani AP. (2018). Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study. The lancet. HIV, 5(9)

Durham DP, Fitzpatrick MC, Ndeffo-Mbah ML, Parpia AS, Michael NL, Galvani AP. (2018). Evaluating Vaccination Strategies for Zika Virus in the Americas. Annals of internal medicine, 168(9)

Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP. (2018). Dynamic Models of Infectious Disease Transmission in Prisons and the General Population. Epidemiologic reviews, 40(1)

Galvani AP, Pandey A, Fitzpatrick MC, Medlock J, Gray GE. (2018). Defining control of HIV epidemics. The lancet. HIV, 5(11)

Lee BY, Bartsch SM, Skrip L, Hertenstein DL, Avelis CM, Ndeffo-Mbah M, Tilchin C, Dumonteil EO, Galvani A. (2018). Are the London Declaration's 2020 goals sufficient to control Chagas disease?: Modeling scenarios for the Yucatan Peninsula. PLoS neglected tropical diseases, 12(3)

Galvani AP, Durham DP, Vermund SH, Fitzpatrick MC. (2017). California Universal Health Care Bill: an economic stimulus and life-saving proposal. Lancet (London, England), 390(10106)

Skrip LA, Fallah MP, Gaffney SG, Yaari R, Yamin D, Huppert A, Bawo L, Nyenswah T, Galvani AP. (2017). Characterizing risk of Ebola transmission based on frequency and type of case-contact exposures. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 372(1721)

Fitzpatrick MC, Singer BH, Hotez PJ, Galvani AP. (2017). Saving lives efficiently across sectors: the need for a Congressional cost-effectiveness committee. Lancet (London, England), 390(10110)

Sah P, Fitzpatrick MC, Pandey A, Galvani AP. (2017). HIV criminalization exacerbates subpar diagnosis and treatment across the United States: response to the 'Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'. AIDS (London, England), 31(17)

Medlock J, Pandey A, Parpia AS, Tang A, Skrip LA, Galvani AP. (2017). Effectiveness of UNAIDS targets and HIV vaccination across 127 countries. Proceedings of the National Academy of Sciences of the United States of America, 114(15)

Galvani AP, Fitzpatrick MC, Vermund SH, Singer BH. (2017). Fund global health: Save lives and money. Science (New York, N.Y.), 356(6342)

Lee BY, Alfaro-Murillo JA, Parpia AS, Asti L, Wedlock PT, Hotez PJ, Galvani AP. (2017). The potential economic burden of Zika in the continental United States. PLoS neglected tropical diseases, 11(4)

Pandey A, Galvani A. (2017). Strategies for Trypanosoma brucei gambiense elimination. The Lancet. Global health, 5(1)

Ndeffo-Mbah ML, Galvani AP. (2017). Global elimination of lymphatic filariasis. The Lancet. Infectious diseases, 17(4)

Fallah MP, Skrip LA, Raftery P, Kullie M, Borbor W, Laney AS, Blackley DJ, Christie A, Dokubo EK, Lo TQ, Coulter S, Baller A, Vonhm BT, Bemah P, Lomax S, Yeiah A, Wapoe-Sackie Y, Mann J, Clement P, Davies-Wayne G, Hamblion E, Wolfe C, Williams D, Gasasira A, Kateh F, Nyenswah TG, Galvani AP. (2017). Bolstering Community Cooperation in Ebola Resurgence Protocols: Combining Field Blood Draw and Point-of-Care Diagnosis. PLoS medicine, 14(1)

Li M, Taylor EG, Atkins KE, Chapman GB, Galvani AP. (2016). Stimulating Influenza Vaccination via Prosocial Motives. PLoS One, 11(7)

Fitzpatrick MC, Shah HA, Pandey A, Bilinski AM, Kakkar M, Clark AD, Townsend JP, Abbas SS, Galvani AP. (2016). One Health approach to cost-effective rabies control in India. Proceedings of the National Academy of Sciences of the United States of America, 113(51)

Galvani AP, Bauch CT, Anand M, Singer BH, Levin SA. (2016). Human-environment interactions in population and ecosystem health. Proceedings of the National Academy of Sciences of the United States of America, 113(51)

Ndeffo-Mbah ML, Parpia AS, Galvani AP. (2016). Mitigating Prenatal Zika Virus Infection in the Americas. Annals of internal medicine, 165(8)

Bilinski AM, Fitzpatrick MC, Rupprecht CE, Paltiel AD, Galvani AP. (2016). Optimal frequency of rabies vaccination campaigns in Sub-Saharan Africa. Proceedings. Biological sciences, 283(1842)

Yamin D, Jones FK, DeVincenzo JP, Gertler S, Kobiler O, Townsend JP, Galvani AP. (2016). Vaccination strategies against respiratory syncytial virus. Proceedings of the National Academy of Sciences of the United States of America, 113(46)

Yamin D, Atkins KE, Remy V, Galvani AP. (2016). Cost-Effectiveness of Rotavirus Vaccination in France-Accounting for Indirect Protection. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 19(6)

Macarayan E, Ndeffo-Mbah M, Beyrer C, Galvani AP. (2016). Philippine drug war and impending public health crisis. Lancet (London, England), 388(10062)

Ndeffo-Mbah ML, Durham DP, Skrip LA, Nsoesie EO, Brownstein JS, Fish D, Galvani AP. (2016). Evaluating the effectiveness of localized control strategies to curtail chikungunya. Scientific reports

Alfaro-Murillo JA, Townsend JP, Galvani AP. (2016). Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US. Vaccine, 34(2)

Durham DP, Ndeffo-Mbah ML, Skrip LA, Jones FK, Bauch CT, Galvani AP. (2016). National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States. Proceedings of the National Academy of Sciences of the United States of America, 113(18)

Ibuka Y, Ohkusa Y, Sugawara T, Chapman GB, Yamin D, Atkins KE, Taniguchi K, Okabe N, Galvani AP. (2016). Social contacts, vaccination decisions and influenza in Japan. Journal of epidemiology and community health, 70(2)

Atkins KE, Pandey A, Wenzel NS, Skrip L, Yamin D, Nyenswah TG, Fallah M, Bawo L, Medlock J, Altice FL, Townsend J, Ndeffo-Mbah ML, Galvani AP. (2016). Retrospective Analysis of the 2014-2015 Ebola Epidemic in Liberia. The American journal of tropical medicine and hygiene, 94(4)

Fallah MP, Skrip LA, Dahn BT, Nyenswah TG, Flumo H, Glayweon M, Lorseh TL, Kaler SG, Higgs ES, Galvani AP. (2016). Pregnancy outcomes in Liberian women who conceived after recovery from Ebola virus disease. The Lancet. Global health, 4(10)

Skrip LA, Galvani AP. (2016). Next Steps for Ebola Vaccination: Deployment in Non-Epidemic, High-Risk Settings. PLoS neglected tropical diseases, 10(8)

Fallah M, Dahn B, Nyenswah TG, Massaquoi M, Skrip LA, Yamin D, Mbah MN, Joe N, Freeman S, Harris T, Benson Z, Galvani AP. (2016). Interrupting Ebola Transmission in Liberia Through Community-Based Initiatives. Annals of internal medicine, 164(5)

Parpia AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP. (2016). Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerging infectious diseases, 22(3)

Gilbert JA, Medlock J, Townsend JP, Aksoy S, Ndeffo Mbah M, Galvani AP. (2016). Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis. PLoS neglected tropical diseases, 10(3)

Taylor E, Atkins KE, Medlock J, Li M, Chapman GB, Galvani AP. (2016). Cross-Cultural Household Influence on Vaccination Decisions. Medical decision making : an international journal of the Society for Medical Decision Making, 36(7)

Gilbert JA, Shenoi SV, Moll AP, Friedland GH, Paltiel AD, Galvani AP. (2016). Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa. PLoS One, 11(12)

Alfaro-Murillo JA, Parpia AS, Fitzpatrick MC, Tamagnan JA, Medlock J, Ndeffo-Mbah ML, Fish D, Ávila-Agüero ML, Marín R, Ko AI, Galvani AP. (2016). A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control. PLoS neglected tropical diseases, 10(5)

Yamin D, Gertler S, Ndeffo-Mbah ML, Galvani AP. (2015). Effect of Ebola progression in Liberia. Annals of internal medicine, 162(10)

Townsend JP, Skrip LA, Galvani AP. (2015). Impact of bed capacity on spatiotemporal shifts in Ebola transmission. Proceedings of the National Academy of Sciences of the United States of America, 112(46)

Atkins KE, Wenzel NS, Ndeffo-Mbah M, Altice FL, Townsend JP, Galvani AP. (2015). Under-reporting and case fatality estimates for emerging epidemics. BMJ (Clinical research ed.)

Fallah M, Skrip LA, d'Harcourt E, Galvani AP. (2015). Strategies to prevent future Ebola epidemics. Lancet (London, England), 386(9989)

Yamin D, Gertler S, Ndeffo-Mbah ML, Skrip LA, Fallah M, Nyenswah TG, Altice FL, Galvani AP. (2015). Effect of Ebola progression on transmission and control in Liberia. Annals of internal medicine, 162(1)

Fallah MP, Skrip LA, Gertler S, Yamin D, Galvani AP. (2015). Quantifying Poverty as a Driver of Ebola Transmission. PLoS neglected tropical diseases, 9(12)

Wells CR, Galvani AP. (2015). Public health impact of disease-behavior dynamics: Comment on "Coupled disease-behavior dynamics on complex networks: A review" by Z. Wang et al. Physics of life reviews

Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP. (2015). Harnessing case isolation and ring vaccination to control Ebola. PLoS neglected tropical diseases, 9(5)

Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP. (2015). Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola. PLoS neglected tropical diseases, 9(6)

Ndeffo Mbah ML, Parikh S, Galvani AP. (2015). Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan Africa. The American journal of tropical medicine and hygiene, 92(3)

Ibuka Y, Li M, Vietri J, Chapman GB, Galvani AP. (2014). Free-riding behavior in vaccination decisions: an experimental study. PLoS One, 9(1)

Pandey A, Atkins KE, Medlock J, Wenzel N, Townsend JP, Childs JE, Nyenswah TG, Ndeffo-Mbah ML, Galvani AP. (2014). Strategies for containing Ebola in West Africa. Science (New York, N.Y.), 346(6212)

Fitzpatrick MC, Hampson K, Cleaveland S, Mzimbiri I, Lankester F, Lembo T, Meyers LA, Paltiel AD, Galvani AP. (2014). Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Annals of internal medicine, 160(2)

Galvani AP, Ndeffo-Mbah ML, Wenzel N, Childs JE. (2014). Ebola vaccination: if not now, when?. Annals of internal medicine, 161(10)

Yamin D, Balicer RD, Galvani AP. (2014). Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel. Vaccine, 32(33)

Ndeffo Mbah ML, Durham DP, Medlock J, Galvani AP. (2014). Country- and age-specific optimal allocation of dengue vaccines. Journal of theoretical biology

Ndeffo Mbah ML, Skrip L, Greenhalgh S, Hotez P, Galvani AP. (2014). Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa. PLoS neglected tropical diseases, 8(10)

Ndeffo Mbah ML, Gilbert JA, Galvani AP. (2014). Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities. Epidemics

Lipsitch M, Galvani AP. (2014). Ethical alternatives to experiments with novel potential pandemic pathogens. PLoS medicine, 11(5)

Lewnard JA, Ndeffo Mbah ML, Alfaro-Murillo JA, Altice FL, Bawo L, Nyenswah TG, Galvani AP. (2014). Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis. The Lancet. Infectious diseases, 14(12)

Skene KJ, Paltiel AD, Shim E, Galvani AP. (2014). A marginal benefit approach for vaccinating influenza "superspreaders". Medical decision making : an international journal of the Society for Medical Decision Making, 34(4)

Durham DP, Ndeffo Mbah ML, Medlock J, Luz PM, Meyers LA, Paltiel AD, Galvani AP. (2013). Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine, 31(37)

Medlock J, Atkins KE, Thomas DN, Aksoy S, Galvani AP. (2013). Evaluating paratransgenesis as a potential control strategy for African trypanosomiasis. PLoS neglected tropical diseases, 7(8)

Ndeffo Mbah ML, Kjetland EF, Atkins KE, Poolman EM, Orenstein EW, Meyers LA, Townsend JP, Galvani AP. (2013). Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proceedings of the National Academy of Sciences of the United States of America, 110(19)

Atkins KE, Townsend JP, Medlock J, Galvani AP. (2013). Epidemiological mechanisms of genetic resistance to kuru. Journal of the Royal Society, Interface, 10(85)

Bauch CT, Galvani AP. (2013). Epidemiology. Social factors in epidemiology. Science (New York, N.Y.), 342(6154)

Ndeffo Mbah ML, Poolman EM, Atkins KE, Orenstein EW, Meyers LA, Townsend JP, Galvani AP. (2013). Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women. PLoS neglected tropical diseases, 7(8)

Mbah MLN, Poolman EM, Drain PK, Coffee MP, van der Werf MJ, Galvani AP. (2013). HIV and Schistosoma haematobium prevalences correlate in sub-Saharan Africa. Tropical medicine & international health : TM & IH, 18(10)

Padmanabha H, Durham D, Correa F, Diuk-Wasser M, Galvani A. (2012). The interactive roles of Aedes aegypti super-production and human density in dengue transmission. PLoS neglected tropical diseases, 6(8)

Fitzpatrick MC, Hampson K, Cleaveland S, Meyers LA, Townsend JP, Galvani AP. (2012). Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania. PLoS neglected tropical diseases, 6(8)

Shim E, Galvani AP. (2012). Distinguishing vaccine efficacy and effectiveness. Vaccine, 30(47)

Karan A, Chapman GB, Galvani A. (2012). The influence of poverty and culture on the transmission of parasitic infections in rural nicaraguan villages. Journal of parasitology research

Ndeffo Mbah ML, Liu J, Bauch CT, Tekel YI, Medlock J, Meyers LA, Galvani AP. (2012). The impact of imitation on vaccination behavior in social contact networks. PLoS computational biology, 8(4)

Atkins KE, Shim E, Pitzer VE, Galvani AP. (2012). Impact of rotavirus vaccination on epidemiological dynamics in England and Wales. Vaccine, 30(3)

Shim E, Chapman GB, Townsend JP, Galvani AP. (2012). The influence of altruism on influenza vaccination decisions. Journal of the Royal Society, Interface, 9(74)

Liu J, Kochin BF, Tekle YI, Galvani AP. (2012). Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel. Journal of the Royal Society, Interface, 9(66)

Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP. (2012). The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine, 30(48)

Ibuka Y, Paltiel AD, Galvani AP. (2012). Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs. Medical decision making : an international journal of the Society for Medical Decision Making, 32(3)

Chapman GB, Li M, Vietri J, Ibuka Y, Thomas D, Yoon H, Galvani AP. (2012). Using game theory to examine incentives in influenza vaccination behavior. Psychological science, 23(9)

Durham DP, Poolman EM, Ibuka Y, Townsend JP, Galvani AP. (2012). Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types. The Journal of infectious diseases, 206(8)

Tsao K, Fish D, Galvani AP. (2012). Predicted outcomes of vaccinating wildlife to reduce human risk of Lyme disease. Vector borne and zoonotic diseases (Larchmont, N.Y.), 12(7)

Shim E, Meyers LA, Galvani AP. (2011). Optimal H1N1 vaccination strategies based on self-interest versus group interest. BMC Public Health

Luz PM, Vanni T, Medlock J, Paltiel AD, Galvani AP. (2011). Dengue vector control strategies in an urban setting: an economic modelling assessment. Lancet (London, England), 377(9778)

Li M, Chapman GB, Ibuka Y, Meyers LA, Galvani A. (2011). Who got vaccinated against H1N1 pandemic influenza? A longitudinal study in four U.S. cities. Psychology & health, 27(1)

Vietri JT, Chapman GB, Li M, Galvani AP. (2011). Preferences for HPV vaccination in parent-child dyads: Similarities and acknowledged differences. Preventive medicine, 52(5)

Davis S, Aksoy S, Galvani A. (2011). A global sensitivity analysis for African sleeping sickness. Parasitology, 138(4)

Reluga TC, Galvani AP. (2011). A general approach for population games with application to vaccination. Mathematical biosciences, 230(2)

Luz PM, Struchiner CJ, Galvani AP. (2010). Modeling transmission dynamics and control of vector-borne neglected tropical diseases. PLoS neglected tropical diseases, 4(10)

Ibuka Y, Chapman GB, Meyers LA, Li M, Galvani AP. (2010). The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC infectious diseases

Shim E, Chapman GB, Galvani AP. (2010). Decision making with regard to antiviral intervention during an influenza pandemic. Medical decision making : an international journal of the Society for Medical Decision Making, 30(4)

Bauch CT, Li M, Chapman G, Galvani AP. (2010). Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?. The Lancet. Infectious diseases, 10(2)

Shim E, Hampson K, Cleaveland S, Galvani AP. (2009). Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. Vaccine, 27(51)

Medlock J, Galvani AP. (2009). Optimizing influenza vaccine distribution. Science (New York, N.Y.), 325(5948)

Shim E, Galvani AP. (2009). Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination. Vaccine, 27(30)

Shim E, Galvani AP. (2009). Evolutionary repercussions of avian culling on host resistance and influenza virulence. PLoS One, 4(5)

Medlock J, Meyers LA, Galvani A. (2009). Optimizing allocation for a delayed influenza vaccination campaign. PLoS currents

Basu S, Friedland GH, Medlock J, Andrews JR, Shah NS, Gandhi NR, Moll A, Moodley P, Sturm AW, Galvani AP. (2009). Averting epidemics of extensively drug-resistant tuberculosis. Proceedings of the National Academy of Sciences of the United States of America, 106(18)

Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP. (2009). Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. The Lancet. Infectious diseases, 9(3)

Medlock J, Luz PM, Struchiner CJ, Galvani AP. (2009). The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes. The American naturalist, 174(4)

Basu S, Galvani AP. (2009). The evolution of tuberculosis virulence. Bulletin of mathematical biology, 71(5)

Reluga TC, Medlock J, Galvani A. (2009). The discounted reproductive number for epidemiology. Mathematical biosciences and engineering : MBE, 6(2)

Shim E, Kochin B, Galvani A. (2009). Insights from epidemiological game theory into gender-specific vaccination against rubella. Mathematical biosciences and engineering : MBE, 6(4)

Poolman EM, Elbasha EH, Galvani AP. (2008). Vaccination and the evolutionary ecology of human papillomavirus. Vaccine

Basu S, Orenstein E, Galvani AP. (2008). The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics. The Journal of infectious diseases, 198(10)

Basu S, Chapman GB, Galvani AP. (2008). Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proceedings of the National Academy of Sciences of the United States of America, 105(48)

Luz PM, Mendes BV, Codeço CT, Struchiner CJ, Galvani AP. (2008). Time series analysis of dengue incidence in Rio de Janeiro, Brazil. The American journal of tropical medicine and hygiene, 79(6)

Galvani AP, Reluga TC, Chapman GB. (2007). Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proceedings of the National Academy of Sciences of the United States of America, 104(13)

Basu S, Galvani AP. (2007). Extensively drug-resistant tuberculosis in South Africa. Lancet (London, England), 369(9558)

Poolman EM, Galvani AP. (2007). Evaluating candidate agents of selective pressure for cystic fibrosis. Journal of the Royal Society, Interface, 4(12)

Basu S, Galvani AP. (2007). Re: "Multiparameter calibration of a natural history model of cervical cancer". American journal of epidemiology, 166(8)

Reluga TC, Medlock J, Poolman E, Galvani AP. (2007). Optimal timing of disease transmission in an age-structured population. Bulletin of mathematical biology, 69(8)

Galvani AP, Medlock J, Chapman GB. (2006). The ethics of influenza vaccination. Science (New York, N.Y.), 313(5788)

Poolman EM, Galvani AP. (2006). Modeling targeted ivermectin treatment for controlling river blindness. The American journal of tropical medicine and hygiene, 75(5)

Reluga TC, Bauch CT, Galvani AP. (2006). Evolving public perceptions and stability in vaccine uptake. Mathematical biosciences, 204(2)

Reluga TC, Medlock J, Galvani AP. (2006). A model of spatial epidemic spread when individuals move within overlapping home ranges. Bulletin of mathematical biology, 68(2)

Galvani AP, May RM. (2005). Epidemiology: dimensions of superspreading. Nature, 438(7066)

Galvani AP. (2005). The role of mutation accumulation in HIV progression. Proceedings. Biological sciences, 272(1574)

Porco TC, Lloyd-Smith JO, Gross KL, Galvani AP. (2005). The effect of treatment on pathogen virulence. Journal of theoretical biology, 233(1)

Elbasha EH, Galvani AP. (2005). Vaccination against multiple HPV types. Mathematical biosciences, 197(1)

Galvani AP, Novembre J. (2005). The evolutionary history of the CCR5-Delta32 HIV-resistance mutation. Microbes and infection, 7(2)

Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP. (2005). Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology (Cambridge, Mass.), 16(6)

Galvani AP. (2005). Age-dependent epidemiological patterns and strain diversity in helminth parasites. The Journal of parasitology, 91(1)

Galvani AP, Slatkin M. (2004). Intense selection in an age-structured population. Proceedings. Biological sciences, 271(1535)

Galvani AP. (2004). Emerging infections: what have we learned from SARS?. Emerging infectious diseases, 10(7)

Galvani AP, Slatkin M. (2003). Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proceedings of the National Academy of Sciences of the United States of America, 100(25)

Galvani AP, Coleman RM, Ferguson NM. (2003). The maintenance of sex in parasites. Proceedings. Biological sciences, 270(1510)

Bauch CT, Galvani AP. (2003). Using network models to approximate spatial point-process models. Mathematical biosciences, 184(1)

Galvani AP, Lei X, Jewell NP. (2003). Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times. Emerging infectious diseases, 9(8)

Galvani AP. (2003). Immunity, antigenic heterogeneity, and aggregation of helminth parasites. The Journal of parasitology, 89(2)